A Randomized Trial of Hydroxyurea Versus VP 16 in Adult Chronic Myelomonocytic Leukemia

[1]  A. Duhamel,et al.  Cytogenetic analysis has strong independent prognostic value in de novo myelodysplastic syndromes and can be incorporated in a new scoring system: a report on 408 cases. , 1993, Leukemia.

[2]  J. Hainsworth,et al.  Bioavailability of low-dose oral etoposide. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  P. Morel,et al.  Prognostic factors in adult de novo myelodysplastic syndromes treated by intensive chemotherapy , 1991, British journal of haematology.

[4]  D. Carney.  The pharmacology of intravenous and oral etoposide , 1991, Cancer.

[5]  R. Beuscart,et al.  Prognostic factors in adult chronic myelomonocytic leukemia: an analysis of 107 cases. , 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  J. Ribera,et al.  A multivariate analysis of prognostic factors in chronic myelomonocytic leukaemia according to the FAB criteria , 1987, British journal of haematology.

[7]  P. Fenaux,et al.  Low-dose cytosine arabinoside in adult chronic myelomonocytic leukemia. , 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  R. Simon,et al.  A critical appraisal of low-dose cytosine arabinoside in patients with acute non-lymphocytic leukemia and myelodysplastic syndromes. , 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  G. Mufti,et al.  Monocytic skin infiltration in chronic myelomonocytic leukaemia. , 1986, Clinical and laboratory haematology.

[10]  Chronic myelomonocytic leukemia: Clinical features, cytogenetics, and prognosis in 30 consecutive cases , 1985, Hematological oncology.

[11]  D. Oscier,et al.  Serous effusions in monocytic leukaemias , 1984, British journal of haematology.

[12]  C. Chastang,et al.  Chronic myelomonocytic leukemia according to FAB classification: analysis of 35 cases. , 1984, Blood.

[13]  H. Gralnick,et al.  Proposals for the classification of the myelodysplastic syndromes , 1982, British journal of haematology.

[14]  David R. Cox,et al.  Regression models and life tables (with discussion , 1972 .